Mutual Fund Details
NAV
₹28.2744
as on 24 Apr 2024, 09:00 PM
₹0.1074(0.38%)
Last Change
Schemes Managed By
Investment Performance
would have given a return of
₹1,10,871
₹1,21,647
₹1,55,834
₹1,63,020
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
₹63,020
Profit (absolute return)
63.02%
in the last
1m
3m
1y
3y
5y
max
+1% Higher Returns
With Direct Plans on Paytm MoneyInvestment Returns
In the last 3 months
4.76%
In the last 6 months
26.13%
In the last 1 year
53.21%
In the last 3 years
63.02%
In the last 5 years
189.39%
In the last 10 years
NA
Absolute Returns
CAGR
Scheme Riskometer
low
low to moderate
moderate
moderately high
high
very high
Investors understand that their principal will be at very high risk
Scheme Information
Tata India Pharma & HealthCare Fund Direct-IDCW
as of 31 Mar 2024, 05:30 AM
₹878.70 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 0.25% if redeemed within 30 days.
0.88%
Expense Ratio
Plan
Dividend
Benchmark
NIFTY Pharma Total Return Index
Exit Load
Exit load of 0.25% if redeemed within 30 days.
Scheme Document
Sectors Holding in this Mutual Fund
as on 31 Mar 2024
Healthcare
92.31%
₹811.13 Cr
Services
2.41%
₹21.18 Cr
Chemicals
1.16%
₹10.19 Cr
Others
4.12%
₹36.20 Cr
Companies Holding in this Mutual Fund
as on 31 Mar 2024
Sun Pharmaceutical Industries Ltd.
14.56%
₹127.94 Cr
Lupin Ltd.
9.39%
₹82.51 Cr
Aurobindo Pharma Ltd.
8.87%
₹77.94 Cr
Cipla Ltd.
7.07%
₹62.12 Cr
Zydus Lifesciences Ltd.
5.40%
₹47.45 Cr
Others
54.71%
₹480.74 Cr
View All
View All
This fund's returns:
17.66%Return Duration
3 Years
SBI Healthcare Opportunities Fund Direct Plan-Growth
EquityPharma
Min. Investment
₹500
Category Returns
12.23%
18.70%
3Y Returns
18.70
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth
EquityPharma
Min. Investment
₹100
Category Returns
12.23%
18.70%
3Y Returns
18.52
Tata India Pharma & HealthCare Fund Direct-Growth
EquityPharma
Min. Investment
₹100
Category Returns
12.23%
18.70%
3Y Returns
17.66
About Tata India Pharma & HealthCare Fund Direct-IDCW
Tata India Pharma & HealthCare Fund Direct-IDCW is a Equity mutual fund scheme from Tata Mutual Fund. This scheme was launched on Invalid date and is currently managed by its fund manager Meeta Shetty. It has an AUM of ₹878.70 Crores and the latest NAV decalared is ₹28.274 as on 25 Apr 2024 at 10:41 am.
Tata India Pharma & HealthCare Fund Direct-IDCW scheme return performance in last 1 year is 53.21%, in last 3 years is 63.02% and 181.76% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.
Scheme Details
| AUM: | ₹878.70 Cr |
| Category: | Equity: Sectoral-Pharma |
| Launch Date: | Invalid date |
| Fund Type: | Open-End |
AMC Information
Tata Mutual Fund
View AMC Details
₹1,36,020.31 Cr
AUM
138
Schemes
Address
9th Floor, Mafatlal Centre,Nariman Point,400021
Phone Number
Phone : 1800-209-0101
Email / Website
Start investing in minutes
Download app to Explore
Scan this QR code to download the app now!
Or download from
